首页> 外文期刊>Journal of drugs in dermatology: JDD >A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Plaque Psoriasis
【24h】

A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Plaque Psoriasis

机译:2阶段,多中心,双盲,随机,车辆控制的临床研究,以评估Halobetasol / Tazarotene固定组合在斑块牛皮癣的治疗中的安全性和疗效

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Psoriasis is a chronic, immune-mediated disease that varies widely in its clinical expression. Treatment options focus on relieving symptoms, reducing inflammation, induration, and scaling, and controlling the extent of the disease. Topical corticosteroids are the mainstay of treatment, however long-term safety remains a concern, particularly with the more potent formulations. Combination therapy with a corticosteroid and tazarotene may improve psoriasis signs at a lower corticosteroid concentration providing a superior safety profile.
机译:背景:牛皮癣是一种慢性免疫介导的疾病,其临床表达中的巨大变化。 治疗方案专注于缓解症状,减少炎症,硬结和缩放,并控制疾病的程度。 局部皮质类固醇是治疗的主要支柱,但长期安全仍然是一个问题,特别是具有更有效的配方。 用皮质类固醇和塔拉替烯的组合疗法可以在较低的皮质类固醇浓度下改善牛皮癣迹象,提供优异的安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号